Archive for January 25th, 2010

Citrix Options Shadow VMWare Earnings (CTXS, VMW)

VMWare Inc. (NYSE: VMW) soared in after-hours trading, and in our earnings summary we already noted that that this sets a very high bar for Citrix Systems Inc. (NASDAQ: CTXS) as a result of the strong virtualization market.  We did not see this options trading in our reviews throughout the trading day, but it turns [...]

Apple Preview… Stock/Options Volume Spike (AAPL)

Apple  Inc. (NASDAQ: AAPL) reports after today’s close and this will be the highlight of the earnings after Monday’s closing bell.  Thomson Reuters has estimates pegged at $2.07 EPS (non-GAAP of course) and revenues of $12.06 billion…  Whispers are significantly higher.  Analysts are close to $240 in price targets, options traders are braced for a [...]

CIENA Runs on Analyst Initiation (CIEN)

CIENA Corporation (NASDAQ: CIEN) is trading up this morning on an analyst call.  Auriga gave it a Buy rating with an $18 target.  The firm has said that the transformational acquisition of Nortel’s metro-ethernet operations is off to a good start.  Shares closed at $12.24 Friday, and shares are up at $12.68 on 25,250 per-market [...]

DryShips Running on Analyst Call (DRYS)

DryShips Inc. (NASDAQ: DRYS) is rallying with the market and also on an analyst upgrade.  The stock of the shipper was raised to Buy from Hold over at Cantor Fitzgerald as part of a sector ratings change.  At 8:53 AM EST we have shares trading up almost 5% at $6.11 on 687,000 shares.  The 52-week [...]

Poniard Analyst Trumps Colorectal Cancer Study News (PARD)

Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) is down despite what appears to be some positive internal news.  Its Phase 2 trial of picoplatin in metastatic colorectal cancer patients met its primary objective as picoplatin in combination with a FOLPI regimen was associated with a statistically significant reduction in neurotoxicity when the results were compared to oxaliplatin [...]

Keryx Showing Positive Colon Cancer Trials (KERX)

Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) is surging after the company reported updated results KRX-0401 as its PI3K/Akt pathway inhibitor for cancer as a combination with Xeloda as a treatment for advanced, metastatic colon cancer.  The P-CAP arm showed a statistically significant advantage for TTP and OS and for the percentage of patients achieving Stable Disease [...]

Pacific Ethanol Trending Higher (PEIX)

Pacific Ethanol, Inc. (NASDAQ: PEIX) is trading higher this morning after continued news on Friday calling for improving conditions for ethanol producers.  At 8:34 AM EST we have shares up 7% at $2.17 on almost 27,000 shares.  The 52-week trading range is $0.20 to $2.75 and average volume is 3.6 million shares. Ethanol stocks have [...]